+499.5%
MRNA vs FN
+17.1%
+482.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +3.1% | -5.4% | -2.1% |
| 7D | +5.5% | -1.7% | +7.2% | +5.4% |
| 30D | +158.7% | -22.0% | +180.7% | +159.5% |
| 3M | +182.1% | -43.0% | +225.1% | +195.0% |
| 6M | +151.8% | -27.7% | +179.6% | +146.0% |
| YTD | +393.6% | -10.5% | +404.1% | +351.9% |
| 1Y | +499.5% | +12.5% | +487.0% | +389.4% |
| All | +499.5% | +17.1% | +482.4% | +389.4% |
Cumulative growth
Daily Returns
Daily percentage return beside FN.
Daily Out/Under-Performance
Portfolio return minus FN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling